DW Healthcare Partners, a healthcare focused private equity firm, has appointed William Tella, former president of Curative Specialty Pharmacy, to its executive in residence programme.
The executive in residence programme engages veteran corporate-level executives to run and consult with the firm’s portfolio companies.
“We are thrilled to have Bill join our EIR programme. His breadth of knowledge will enable us to identify and operate a world-class specialty pharmacy business within our portfolio," says Andrew Carragher, founder and managing director of DW Healthcare Partners.
Tella brings over 20 years of experience in the healthcare service industry. He has led three healthcare companies, taking one from start-up to over USD225m in revenue. As president of Curative Specialty Pharmacy, he was responsible for the identification and integration of over 11 acquisitions resulting in one of the largest national specialty pharmacy distributors. Curative was subsequently sold to Medco.
"I am excited to join the executive in residence programme and to work with the DW Healthcare team as we actively look to enter the expanding specialty pharmacy sector. They have an exceptional team of healthcare executives with in-depth strategic knowledge to support our expansion efforts," says Tella.
